Created to ensure customers can detect new drug-use trends and keep up with a rapidly changing illicit drug market, the testing panel spans 50+ drugs and metabolites, including New Psychoactive Substances (NPS).
This wider panel provides more data to make informed decisions to minimise the risk when prescribing/determining treatment in order to improve donor safety. All of this with just one sample, one step and one panel, leading to faster treatment decisions.
Drug and metabolites available for testing with Verum
Increase in drug detections with Verum in comparison to traditional tests
Drugs and/or metabolites detected were previously not available using traditional laboratory tests
Increase in number of positive samples
Of samples were positive for at least one drug or metabolite
Illicit sedatives and opioids
Gabapentinoids and prescription only sedatives
Get in touch to discuss how Verum can benefit your business.
The percentages and numbers displayed in the ‘Informed Decision’ section of this page are generated from data for oral fluid samples received at our laboratory and testing for the Verum Panel between March 2019 and February 2020.
A Leader in Toxicology
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Abbott - A Global Leader in Toxicology.
Alere Toxicology is now Abbott Toxicology